Use of the Omnipod 5 led to an HbA1c reduction of 0.8 percentage points at 13 weeks for adults with type 2 diabetes. FDA cleared the device for use in adults with type 2 diabetes in August.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback